Form 4: Collegium Pharmaceutical Director Receives Stock Grant

Rita J. Balice-Gordon, a director at Collegium Pharmaceutical, received a grant of restricted stock units on May 16, 2024.

Summary

• Rita J. Balice-Gordon, a director of Collegium Pharmaceutical, Inc., reported a transaction on May 16, 2024.
• She acquired 7,693 shares of common stock through the grant of restricted stock units (RSUs).
• The RSUs vest on May 16, 2025, contingent upon her continued service as a director.
• Each RSU represents the right to receive one share of Collegium Pharmaceutical's common stock.
• Following the transaction, Balice-Gordon beneficially owns 46,488 shares of common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grant of RSUs is a standard practice and indicates confidence in the director's continued service and the company's future.

Positives

• The grant of RSUs aligns the director's interests with the company's long-term performance.
• The vesting period encourages continued service and commitment from the director.

Future Outlook

The RSUs will be settled on the vesting date or earlier upon certain events like the director's end of service, death, disability, or a change in control of the Issuer.

Industry Context

Stock grants to directors are a common practice in the pharmaceutical industry to incentivize and align their interests with the company's success. This aligns with standard compensation practices for board members in publicly traded companies.

Comparison to Industry Standards

• Companies like Amgen, Pfizer, and Johnson & Johnson also use stock grants as part of their director compensation packages.
• The vesting schedules and amounts of RSUs are generally comparable to industry benchmarks for similar-sized pharmaceutical companies.
• Director compensation packages often include a mix of cash and equity to align interests with shareholders.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns the director's interests with the company's performance.
• The director is incentivized to contribute to the company's success to realize the value of the RSUs.

Key Dates